Axonal damage induced by cerebrospinal fluid from patients with relapsing-remitting multiple sclerosis

被引:54
作者
Alcázar, A
Regidor, I
Masjuan, J
Salinas, M
Alvarez-Cermeño, JC
机构
[1] Hosp Ramon & Cajal, Serv Neurol, E-28034 Madrid, Spain
[2] Hosp Ramon & Cajal, Serv Bioquim Invest, E-28034 Madrid, Spain
[3] Univ Alcala de Henares, Dept Med, Alcala De Henares, Spain
关键词
apoptosis; axonal damage; cerebrospinal fluid; cultured neurons; multiple sclerosis;
D O I
10.1016/S0165-5728(99)00225-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The importance of axonal damage in multiple sclerosis (MS) has been recently stressed in proton magnetic resonance spectroscopy and pathological studies, but the exact mechanism producing this damage is unknown. The aim of our study was to ascertain whether soluble mediators present in the cerebrospinal fluid (CSF) of patients with relapsing-remitting MS could induce neuron injury in culture. Different biochemical and cytochemical parameters were determined in primary embryonal rat neuron cultures following 8 days of exposure to CSF. Cytotoxic activity was evaluated with a blue formazan production colorimetric assay. Morphological and immunocytochemical studies performed with antibodies against beta-tubulin revealed neuritic fragmentation, axonal damage and cellular shrinkage indicating apoptosis, Detection of apoptosis was carried out using the fluorescent DNA-binding dye Hoechst 33342, as well as by a Terminal deoxynucleotidyl transferase-mediated dUTP Nick End-Labeling assay. We observed that soluble factors in CSF from patients with "aggressive" MS i.e, those with poor recovery after relapses, induced neurite breakdown and neuronal apoptosis in cultures. Neuron injury is not related with blood-brain barrier dysfunction nor with IgG index. Interestingly, CSF from patients with "non-aggressive" MS i.e., relapsing-remitting patients with a good recovery after relapses, did not induce any damage. In conclusion, we report that CSF from patients with aggressive MS bears soluble mediators that induce axonal damage and apoptosis of neurons in culture. These mediators can be present during the first attack of the disease, and the neuronal damage caused could be related to the functional deficit of these MS patients. (C) 2000 Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:58 / 67
页数:10
相关论文
共 50 条
[41]   Natalizumab use in pediatric patients with relapsing-remitting multiple sclerosis [J].
Arnal-Garcia, Carmen ;
Rosa Garcia-Montero, Ma ;
Malaga, Ignacio ;
Millan-Pascual, Jorge ;
Oliva-Nacarino, Pedro ;
Ramio-Torrenta, Lluis ;
Oreja-Guevara, Celia .
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2013, 17 (01) :50-54
[42]   Sexual dysfunction in female patients with relapsing-remitting multiple sclerosis [J].
Bartnik, Pawel ;
Wielgos, Aleksandra ;
Kacperczyk, Joanna ;
Pisarz, Katarzyna ;
Szymusik, Iwona ;
Podlecka-Pietowska, Aleksandra ;
Zakrzewska-Pniewska, Beata ;
Wielgos, Miroslaw .
BRAIN AND BEHAVIOR, 2017, 7 (06)
[43]   Deregulation of microRNA-181c in cerebrospinal fluid of patients with clinically isolated syndrome is associated with early conversion to relapsing-remitting multiple sclerosis [J].
Ahlbrecht, Jonas ;
Martino, Filippo ;
Pul, Refik ;
Skripuletz, Thomas ;
Suehs, Kurt-Wolfram ;
Schauerte, Celina ;
Yildiz, Oezlem ;
Trebst, Corinna ;
Tasto, Lars ;
Thum, Sabrina ;
Pfanne, Angelika ;
Roesler, Romy ;
Lauda, Florian ;
Hecker, Michael ;
Zettl, Uwe K. ;
Tumani, Hayrettin ;
Thum, Thomas ;
Stangel, Martin .
MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (09) :1202-1214
[44]   Quantitative MRI and Cerebrospinal Fluid Inflammatory Mediators in Brazilian Patients with Relapsing-Remitting Multiple Sclerosis before and after Treatment with Immunomodulators: A Longitudinal Study [J].
Ruocco, Heloisa H. ;
Brandao, Carlos Otavio ;
Farias, Alessandro S. ;
Oliveira, Celina ;
Oliveira, Elaine C. ;
Cendes, Fernando ;
Damasceno, Benito P. ;
Santos, Leonilda M. B. .
NEUROIMMUNOMODULATION, 2012, 19 (05) :277-282
[45]   Facial emotion recognition in patients with relapsing-remitting multiple sclerosis [J].
Fereydouni, Soodabe ;
Hadianfard, Habib ;
Ashjazadeh, Nahid .
NEUROLOGY ASIA, 2019, 24 (04) :327-332
[46]   Serum and Cerebrospinal Fluid Prolactin levels in Male and Female Patients with Clinically-Isolated Syndrome or Relapsing-Remitting Multiple Sclerosis [J].
Markianos, M. ;
Koutsis, G. ;
Evangelopoulos, M. E. ;
Mandellos, D. ;
Sfagos, C. .
JOURNAL OF NEUROENDOCRINOLOGY, 2010, 22 (06) :503-508
[47]   PROGNOSIS OF DISABILITY IN RELAPSING-REMITTING MULTIPLE SCLEROSIS [J].
Somilo, O., V ;
Kalbus, O., I ;
Makarov, S. O. ;
Sorokin, A. V. ;
Shastun, N. P. .
WORLD OF MEDICINE AND BIOLOGY, 2023, 84 (02) :147-152
[48]   Executive functions in relapsing-remitting multiple sclerosis [J].
Elosua, M. Rosa ;
Villadangos, Noelia .
APPLIED NEUROPSYCHOLOGY-ADULT, 2025, 32 (04) :944-952
[49]   Intestinal Permeability in Relapsing-Remitting Multiple Sclerosis [J].
Buscarinu, M. C. ;
Romano, S. ;
Mechelli, R. ;
Umeton, R. Pizzolato ;
Ferraldeschi, M. ;
Fornasiero, A. ;
Renie, R. ;
Cerasoli, B. ;
Morena, E. ;
Romano, C. ;
Loizzo, N. D. ;
Umeton, R. ;
Salvetti, M. ;
Ristori, G. .
NEUROTHERAPEUTICS, 2018, 15 (01) :68-74
[50]   Multi-Platform Characterization of Cerebrospinal Fluid and Serum Metabolome of Patients Affected by Relapsing-Remitting and Primary Progressive Multiple Sclerosis [J].
Murgia, Federica ;
Lorefice, Lorena ;
Poddighe, Simone ;
Fenu, Giuseppe ;
Secci, Maria Antonietta ;
Marrosu, Maria Giovanna ;
Cocco, Eleonora ;
Atzori, Luigi .
JOURNAL OF CLINICAL MEDICINE, 2020, 9 (03)